IP Library Granted Patent US 9,642,866
Granted Patent B2
US 9,642,866 · App. 15/095,248 · Granted May 9, 2017

System and method for diagnosis and treatment

Inventors: Randice Lisa Altschul (Cliffside Park, NJ); Neil David Theise (New York, NY); Myron Rapkin (Indianapolis, IN); Rebecca O'Brien (Shell Knob, MO)
Assignee: Pop Test Oncology Limited Liability Company
A61K31/58A61J1/10A61K9/0019A61K9/08A61K9/10A61K9/107A61K31/337A61K38/09A61K45/06A61K47/10A61K47/26A61K47/34A61K47/42A61K47/44A61K51/00A61N5/1001B65D75/002B65D75/36B65D75/367C07J17/00G01N33/743G01N2333/575G01N2800/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,642,866
App. No.
15/095,248
Granted
May 9, 2017
Kind
B2
Abstract

This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy utilizing a GCR antagonist, such as ORG 34517. The rapid, sensitive, and inexpensive test can be used to determine patients who have non-normal cortisol production or disordered circadian rhythms as a method for selecting subjects for GCR antagonist therapy for whom it is likely to have beneficial and/or therapeutic effects, and can also be used to monitor changes in cortisol levels in response to treatment.

Claims (11)

1. A method of treating post-traumatic stress disorder in a patient in need thereof comprising:

selecting a patient in need of treatment of post-traumatic stress disorder wherein said patient has elevated cortisol levels;

administering the GCR antagonist ORG 34517,

thereby treating post-traumatic stress disorder in the patient.

2. The method of claim 1 , wherein the patient's cortisol levels are measured in a test sample selected from the group consisting of saliva, blood, plasma, serum, urine, other bodily fluids, and combinations thereof.

3. The method of claim 2 , wherein the test sample is obtained from the patient at at least one predetermined time, wherein the predetermined time is selected from the group consisting of morning, noon, and evening.

4. The method of claim 2 , wherein the test sample is obtained from the patient over consecutive days.

5. The method of claim 1 , wherein the method further comprises determining the circadian cycle of the cortisol levels in the patient at a predetermined time, wherein the predetermined time is selected from the group consisting of hourly, every 4 hours, every 6 hours, every 8 hours, and every 12 hours.

6. The method of claim 5 , wherein the test sample is obtained from the patient over consecutive days.

7. The method of claim 1 , wherein said patient's cortisol level is compared to a predetermined reference range, wherein the predetermined reference range is a medically standard reference range.

8. The method of claim 1 , wherein said patient's cortisol level is compared to a predetermined reference range, wherein the predetermined reference range is the patient's previously measured level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: ALTSCHUL, RANDICE LISA; THEISE, NEIL DAVID; RAPKIN, MYRON; O'BRIEN, REBECCA
To: POP TEST ONCOLOGY LIMITED LIABILITY COMPANY
Reel/Frame 038241/0348 →
Continuity (9)
Division 14802060 · Jul 17, 2015
Continuation In Part 14100714 · Dec 9, 2013
Division 13364651 · Feb 2, 2012
Provisional Application 61462492 · Feb 3, 2011
Provisional Application 61463212 · Feb 14, 2011
Provisional Application 61465703 · Mar 23, 2011
Provisional Application 61518248 · May 3, 2011
Provisional Application 61519323 · May 20, 2011
Related Publication 20160279148A1 · Sep 29, 2016